Honasa Adds Over 45K Stock Options to the ESOP Pool

Honasa Adds Over 45K Stock Options to the ESOP Pool
Honasa Increases ESOP Pool with 45,000+ New Stock Options

The awarding of 45,663 stock options under the employee stock option plan (ESOP) has been approved by Honasa Consumer Ltd., the company that owns modern FMCG brands like Mamaearth and The Derma Co. According to its BSE filing, the company's nominating and compensation committee has authorised "a total grant of 45,663 stock options under Honasa Consumer Limited Employee Stock Options Plan—2018 ("ESOP—2018") to the eligible employees." The new stock options were worth INR 1.12 Cr based on the stock's closing price on 17 January. The face value of each equity share is INR 10, and the exercise price is also fixed at INR 10. According to Honasa's petition, an employee may use their vested options during their employment or within ninety days after their final day of employment. The allocation of 546,601 stock options under the same ESOP scheme was approved by the firm in September.

Honasa Roped in Lokesh Chhaparwal as Senior Vice President

Honasa hired Lokesh Chhaparwal as senior vice president of technology and engineering earlier this month, which coincided with the recent ESOP expansion. With an emphasis on using cutting-edge technological solutions to improve operations, Chhaparwal is expected to spearhead the organisation's technological strategy. According to the corporation, his duties would include overseeing digital platforms, using SAP systems to optimise supply chain operations, and developing marketing technology to deliver individualised customer experiences. He will also supervise internal security protocols to protect information and guarantee operational effectiveness.

Chhaparwal, a former AVP and Head of Engineering at Snapdeal, provides more than 13 years of experience in data strategy and product engineering. He will work out of Honasa's Gurgaon office and support the company's initiatives to use technology to build new products and engage customers.

Further Developments at Honasa

In terms of finances, Honasa reported a consolidated net loss of INR 18.6 Cr for the September 2024 (Q2 2025) quarter, compared to a net profit of INR 29.4 Cr for the previous year and INR 40.3 Cr for the June quarter prior. Honasa's top line for D2C brands suffered as well, as operating revenue dropped by almost 7% to INR 461.8 Cr in the reviewed quarter from INR 496.1 Cr in Q2 FY24. Mamaearth, The Derma Co., Aqualogica, Ayuga, BBlunt, and Dr. Sheth's are among the six beauty and personal care brands that make up Honasa's product line. The company was founded in 2016 by Varun and Ghazal Alagh, a husband and wife team.

In the midst of media stories about credit backlogs and unsold stock with distributors, Honasa had provided clarification on the extent of its remaining inventory. The company stated that, in contrast to the All India Consumer Products Distributors Federation's claimed amount of INR 300 crore of near-expiry inventory, its distribution value chain contained a total inventory of INR 40.69 crore.


Manipal Health Prepares $1 Billion IPO Backed by Temasek
Manipal Health, backed by Temasek, is planning a $1 billion IPO and has begun seeking banker presentations to move forward.

Read more